三鑫医疗公告,公司及控股子公司宁波菲拉尔近日分别获得国家药品监督管理局颁发的《医疗器械注册证》。公司获得的血液透析滤过器注册证,适用于急性或慢性肾功能衰竭患者的血液透析、血液透析滤过治疗。
三鑫医疗:公司及控股子公司获得医疗器械注册证
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.